Work

Nanobody-based CD19/CD20 bispecific CAR-T achieves durable remissions in r/r NHL patients

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3724

Authors: Na Kuang, Shuyu Qiang, Lin Wang, Shuhong Li, Liang Huang

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417012613

Cites:

Cited by:

Related to: